this issue
previous article in this issuenext article in this issue

Document Details :

Title: Prevention and treatment of thromboembolic events in medical patients and new anticoagulants
Author(s): BALARATNAM S
Journal: Acta Clinica Belgica
Volume: 64    Issue: 6   Date: 2009   
Pages: 547-552
DOI: 10.2143/ACB.64.6.1002535

Abstract :






VTE presents a significant clinical and economic burden on healthcare. Previous strategies (chemical and mechanical) were not full-proof when used in isolation. The advent of more recent treatments such as factor Xa inhibitors and direct thrombin inhibitors may help to provide more conclusive preventative management of patients at risk of VTE. However, it is important to remember that treatments should be tailored to the individual patient, and the management of VTE will remain a multi-disciplinary specialty, requiring input from general physicians, haematologists, radiologists and pathologists.